Mountain High Acquisitions (MYHI) 10-K 14 Jul 16 2016 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Mar. 31, 2016	Jul. 14, 2016
Document And Entity Information
Entity Registrant Name	Mountain High Acquisitions Corp.
Entity Central Index Key	1,507,181
Document Type	10-K
Document Period End Date	Mar. 31, 2016
Amendment Flag	false
Current Fiscal Year End Date	--03-31
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Smaller Reporting Company
Entity Public Float	$ 1,065,344
Entity Common Stock, Shares Outstanding		44,750,221
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2,016

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($)	Mar. 31, 2016	Mar. 31, 2015
CURRENT ASSETS
Cash and cash equivalents	$ 34,988	$ 45
Inventory	59,296
TOTAL CURRENT ASSETS	94,284	45
ADVANCES		50,000
TOTAL ASSETS	94,284	50,045
CURRENT LIABILITIES
Accounts payable	91,344	97,479
Accrued payroll	37,500
Notes payable, net Beneficial Conversion Feature fully recognized of $173,798	396,022	48,521
Advances from Related Parties	16,100	441,895
TOTAL CURRENT LIABILITIES	540,966	587,895
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' EQUITY (DEFICIT):
Preferred stock, $0.0001 par value; 250,000,000 shares authorized, nil shares issued and outstanding
Common stock, $0.0001 par value; 250,000,000 shares authorized, 33,418,934 and 24,142,000 shares issued and outstanding respectively	3,342	2,414
Additional paid in capital	4,946,691	1,917,976
Accumulated (deficit)	(5,396,715)	(2,458,240)
TOTAL STOCKHOLDERS' EQUITY (DEFICIT)	(446,682)	(537,850)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	$ 94,284	$ 50,045

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)	Mar. 31, 2016	Mar. 31, 2015
Statement of Financial Position [Abstract]
Beneficial Conversion Feature on notes payable, fully recognized	$ 173,798
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, authorized	250,000,000	250,000,000
Preferred stock, issued
Preferred stock, outstanding
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, authorized	250,000,000	250,000,000
Common stock, issued	33,418,934	24,142,000
Common stock, outstanding	33,418,934	24,142,000

CONSOLIDATED STATEMENT OF OPERA

CONSOLIDATED STATEMENT OF OPERATIONS - USD ($)	12 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Income Statement [Abstract]
Revenue	$ 23,057
Cost of revenue	2,204
Gross profit	20,853
Selling, general and administrative expenses	328,841	1,434,160
Impairment	2,300,000
Operating expenses	2,628,841	1,434,160
(Loss) from operations	(2,607,988)	(1,434,160)
Interest Expense resulting from Beneficial Conversion Feature	(173,798)
Other income (expense)	(156,689)
Net (loss) before discontinued operations	(2,938,475)	(1,434,160)
Loss on discontinued operations		(890,473)
Net income (loss)	$ (2,938,475)	$ (2,324,633)
Weighted average shares outstanding - basic and diluted	28,079,857	23,982,315
(Loss) per shares - basic and diluted discontinued operations		$ (0.04)
(Loss) per shares - basic and diluted	$ (0.10)	$ (0.06)

CONSOLIDATED STATEMENT OF STOCK

CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Beginning balance, shares at Jan. 29, 2014
Beginning balance, amount at Jan. 29, 2014
Shares issued for cash, shares	8,104,000
Shares issued for cash, amount	$ 810	610,690		611,500
Shares issued in connection with recapitalization/reverse merger, shares	15,788,000
Shares issued in connection with recapitalization/reverse merger, amount	$ 1,579	(37,689)		(36,110)
Net (loss)			(133,607)	(133,607)
Ending balance, shares at Mar. 31, 2014	23,892,000
Ending balance, amount at Mar. 31, 2014	$ 2,389	573,001	(133,607)	411,783
Fair value of warrants issued for services		1,257,000		1,257,000
Proceeds received for shares not issued at Mar. 31, 2015		63,000		$ 63,000
Shares issued in lieu of compensation, shares	250,000			250,000
Shares issued in lieu of compensation, amount	$ 25	24,975		$ 25,000
Net (loss)			(2,324,633)	(2,324,633)
Ending balance, shares at Mar. 31, 2015	24,142,000
Ending balance, amount at Mar. 31, 2015	$ 2,414	1,917,976	(2,458,240)	(537,850)
Fair value of warrants issued for services
Issue shares for proceeds received, shares	420,000
Issue shares for proceeds received, amount	$ 42	(42)
Private placement, shares	503,334
Private placement, amount	$ 51	75,449		75,500
Purchase GreenLife, shares	10,000,000
Purchase GreenLife, amount	$ 1,000	2,299,000		$ 2,300,000
Retire shares from reverse merger, shares	(2,000,000)			(2,000,000)
Retire shares from reverse merger, amount	$ (200)	200
Shares issued in lieu of compensation, shares	353,600			353,600
Shares issued in lieu of compensation, amount	$ 35	88,365		$ 88,400
Sale of Canna-Life		391,945		391,945
Convertible Note Payable Beneficial Conversion Feature		173,798		173,798
Net (loss)			(2,938,475)	(2,938,475)
Ending balance, shares at Mar. 31, 2016	33,418,934
Ending balance, amount at Mar. 31, 2016	$ 3,342	$ 4,946,691	$ (5,396,715)	$ (446,682)

CONSOLIDATED STATEMENT OF CASH

CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)	12 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
CASH FLOWS FROM OPERATING ACTIVITIES
Net (loss)	$ (2,938,475)	$ (2,324,633)
Adjustments to reconcile net loss to net cash used in operating activities:
Fair value of warrants issued for consulting services		1,257,000
Fair value of shares issued for Director seat	88,400	25,000
Changes in Deposits for acquisitions
Changes in Impairment goodwill	2,300,000
Changes in Advances to Affiliate	50,000	(50,000)
Changes in Beneficial Conversion Feature on Note payable	173,798
Changes in Accounts payable	(6,135)
Changes in Extinguishment of debt	53,040
Changes in Accrued liabilities	37,500
Changes in Related parties	16,100
Changes in Inventory	(59,296)
Changes in Current liabilities	17,629	94,615
Changes in Discontinued operations		890,473
Net cash used in operating activities	(355,839)	(107,545)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of GreenLife	2,669
Disposition of Canna-Life	41,923
Net cash used in investing activities	44,592
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from sale of shares	75,500	63,000
Proceeds from notes payable	270,690	9,762
Proceeds from advances from stockholder		34,017
Net cash provided by financing activities	346,190	106,779
NET DECREASE IN CASH AND CASH EQUIVALENTS	34,943	(766)
CASH AND CASH EQUIVALENTS, Beginning of the period	45	811
CASH AND CASH EQUIVALENTS, End of the period	34,988	45
Supplemental disclosures of cash flow information
Taxes paid
Interest paid

Organization and Basis of Prese

Organization and Basis of Presentation	12 Months Ended
	Mar. 31, 2016
Accounting Policies [Abstract]
Organization and Basis of Presentation	Note 1 - Organization and Basis of Presentation Organization and Line of Business Mountain High Acquisitions Corp., formerly known as Wireless Attachments, Inc., (the “Company”, "MYHI") was incorporated under the laws of the State of Colorado on September 22, 2010. The Company was incorporated for the purpose of developing solar cloth membranes for outdoor active wear that covert sunlight into electrical power and that can be used for charging and/or operating mobile devices such as the iPod and the iPhone. Canna-Life Corporation (“Canna-Life”) was incorporated in the State of Colorado on January 29, 2014. On March 6, 2014, the Company entered into a share exchange agreement with Canna-Life. Pursuant to the agreement, the Company acquired from Canna-Life all of the issued and outstanding capital stock consisting of 8,104,000 shares of common stock in exchange for 8,104,000 shares of the Company’s common stock. Concurrently with the closing of the transaction, Alan Smith, Chief Executive Officer of Canna-Life purchased 120,000,000 shares of the Company’s common stock from the Company’s majority stockholder. In addition, Mr. Smith then entered into an agreement with the Company pursuant to which he returned 113,500,000 shares of the Company’s common stock for cancellation. Mr. Smith was not compensated for the cancellation of his shares of the Company’s common stock. Upon completion of the foregoing transactions, the Company had an aggregate of 23,892,000 shares of common stock issued and outstanding of which 14,604,000 shares (61%) were owned by the former stockholders of Canna-Life. The exchange of shares with Canna-Life was accounted for as a reverse acquisition under the purchase method of accounting since Canna-Life obtained control of the Company and the Chief Executive Officer of Canna-Life became the Chief Executive Officer and sole director of the Company. Accordingly, the merger of Canna-Life into the Company was recorded as a recapitalization of Canna-Life, Canna-Life being treated as the continuing entity. The historical financial statements presented are the financial statements of Canna-Life. The share exchange agreement has been treated as a recapitalization and not as a business combination; therefore, no pro forma information is disclosed. At the date of this transaction, the net liabilities of the legal acquirer, Mountain High Acquisitions Corp, were $36,110. On April 30, 2015, the Company entered into a Sale and Purchase Agreement to sell Canna-Life Corporation (the "CL Agreement") to Evolution Equities Corporation and Alan Smith ("Purchasers"). Under the terms of the CL Agreement the Company sold 8,104,000 (100%) of its shares of Canna-Life and execute a Note Payable for $80,000 to Evolution Equities Corporation in exchange for the extinguishment of $490,416 of debt due to the Purchasers at March 31, 2015 and $1.00 cash. As a result of this transaction all activity for Canna-Life has been reclassified as discontinued operations in the financial statements for MYHI. On May 19, 2015, the Company entered into the First Amendment to the Share Exchange Agreement with Freedom Seed and Feed Shareholders, the "FSF Agreement" or "FSF", to acquire the controlling shares of Freedom Feed and Seed in exchange for 31,429,000 shares of MYHI. During the due diligence process the Company advanced $75,645.30 to FSF for operating expenses. The Company executed notes payable for the advanced funds. On June 30, 2015, the Company executed a Rescission Agreement with FSF canceling the FSF Agreement. The Company was unable to collect the amounts advanced to FSF and wrote off the advance to Other Income (Expense) in June 2015. On May 22, 2015 the Company completed the acquisition of Greenlife Botanix ("Greenlife") as detailed in the First Amendment to the Shareholder Agreement dated February 8, 2015. The Company issued 10,000,000 restricted shares of its common stock to the shareholders of Greenlife in exchange for their 100% interest in Greenlife. The shares were valued at the market value on the date of issuance, $0.23, for a total consideration of $2,300,000. The amount paid for Greenlife was recorded as Goodwill due to the start up nature of Greenlife and the minimal net assets of Greenlife at the time of acquisition. Subsequent to the purchase of Greenlife the Company entered into a rescission agreement with Freedom Seed and Feed, "FSF", which impaired the integration of Greenlife and FSF into a fully integrated cosmetic company. Due to the rescission of FSF and the remarketing of the Greenlife product line the Company evaluated the book value of the asset and elected to impair the Goodwill value of Greenlife and expensed the $2,300,000 book value in the year ended March 31, 2016.

Going Concern

Going Concern	12 Months Ended
	Mar. 31, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern	Going Concern The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of the Company as a going concern. The Company has incurred a net loss of $2,938,475 and used cash for operations of $355,839 for the year ended March 31, 2016 and has an accumulated deficit of $5,396,715 and a working capital deficit of $446,682 as of March 31, 2016. These conditions raise substantial doubt as to the Company’s ability to continue as a going concern. These consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. These consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. Management plans to continue to raise capital to fund the Company’s operations and believes that it can continue to raise equity or debt financing to support its operations until the Company is able to generate positive cash flow from operations.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Mar. 31, 2016
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2 – Summary of Significant Accounting Policies Basis of Presentation The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“US GAAP”). The accompanying consolidated financial statements have been presented in United States Dollars ($ or “USD”). The fiscal year end is March 31. Principles of Consolidation The accounts of the Company and its wholly–owned subsidiary GreenLife Botanix are included in the accompanying consolidated financial statements. All intercompany balances and transactions were eliminated in consolidation. Use of Estimates The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. It is possible that accounting estimates and assumptions may be material to the Company due to the levels of subjectivity and judgment involved. Cash and Cash Equivalents Cash and cash equivalents include cash on hand and cash in time deposits, certificates of deposit and all highly liquid debt instruments with original maturities of three months or less. Revenue Recognition In accordance with the Securities and Exchange Commission’s (“SEC”) Staff Accounting Bulletin No. 104, Revenue Recognition Persuasive evidence of an arrangement exists Delivery has occurred The sales price is fixed or determinable Collection is reasonably assured Inventories Inventories consisting of cosmetic products are stated at the lower of cost or market. Cost is determined using the first-in, first-out method and are adjusted to actual cost quarterly based on a physical count. Net realizable value is the estimated selling price in the ordinary course of business, less applicable variable selling expenses. Intangible Assets The Company accounts for intangibles in accordance with ASC 350, Intangible-Goodwill and Other. The Company evaluates intangibles, at a minimum, on an annual basis and whenever events and changes in circumstances suggest that the carrying amount may not be recoverable. Impairment of intangibles is tested by comparing the carrying amount to the fair value. The fair values are estimated using undiscounted projected net cash flows. If the carrying amount exceeds its fair value, intangibles are considered impaired and a second step is performed to measure the amount of impairment loss, if any. The Company evaluates the impairment of intangibles as of the end of each fiscal year or whenever events or changes in circumstances indicate that an intangible asset’s carrying amount may not be recoverable. These circumstances include: · a significant decrease in the market value of an asset; · a significant adverse change in the extent or manner in which an asset is used; or · an accumulation of costs significantly in excess of the amount originally expected for the acquisition of an asset. The Company recognized an impairment expense related to intangible assets during the year ended March 31, 2016 of $2,300,000 and nil for the Income Taxes The Company accounts for income taxes in accordance with ASC Topic 740, Income Taxes Under ASC 740, a tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination. For tax positions not meeting the “more likely than not” test, no tax benefit is recorded. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above is reflected as a liability for unrecognized tax benefits in the balance sheets along with any associated interest and penalties that would be payable to the taxing authorities upon examination. Applicable interest and penalties associated with unrecognized tax benefits are classified as additional income taxes in the statements of operations. The open tax years are 2011, 2012, 2013, 2014, 2015 and 2016. The Company has no tax positions at March 31, 2016, or March 31, 2015, for which the ultimate deductibility is highly certain but for which there is uncertainty about the timing of such deductibility. Basic and Diluted Loss Per Share Earnings per share is calculated in accordance with the ASC Topic 260, Earnings Per Share Discontinued Operations The Generally Accepted Accounting Principles framework requires special presentation treatment of discontinued operations. This requirement refers to the results of operations of a component of an entity that is either being held for sale or which has already been disposed of. The designated results of operations must be reported as a discontinued operation within the financial statements if both of the following conditions are present: · Resulting elimination . The disposal transaction will result in the operations and cash flows of the component being eliminated from company operations. · Continuing involvement . There will be no significant continuing involvement by the company in the operations of the component, once the disposal transaction has been completed. Continuing involvement implies the ability to influence the operating or financial policies of the disposed component. Due to the above requirements, the financial results relating to Canna-Life are classified as discontinued operations in the MYHI consolidated financial statements. Recent Accounting Pronouncements In April 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2014-08, Presentation of Financial Statements (Topic 205) and Property, Plant and Equipment (Topic 360) In September 2014, the FASB issued ASU No. 2014-10, Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation which removes the definition of a development stage entity from Topic 915, thereby removing the distinction between development stage entities and other reporting entities from U.S. GAAP. In addition, the amendments eliminate the requirements for development stage entities to (1) present inception-to-date information on the statements of operations, cash flows, and stockholders’ equity, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage. The amendment is effective for annual reporting periods beginning after December 15, 2014. Early application is permitted. The Company chose to adopt ASU No. 2014-10 in the period ended March 31, 2014. Other recent authoritative guidance issued by the FASB (including technical corrections to the FASB Accounting Standards Codification), the American Institute of Certified Public Accountants, and the SEC, did not, or are not expected to have a material effect on the Company’s consolidated financial statements.

Advances from Stockholder

Advances from Stockholder	12 Months Ended
	Mar. 31, 2016
Debt Disclosure [Abstract]
Advances from Stockholder	Note 3 – Advances from Stockholder Alan Smith, the Company’s Chief Executive officer and a director, has advanced money to fund the Company’s operations. The amount due to this stockholder at March 31, 2016 and March 31, 2015 was a 5% convertible note payable of $15,001 and an unsecured liability of $441,895, respectively. The $16,100 Advances from related parties refers to an unsecured advance by the President of GreenLife Botanix, Brent McMahon. Mr. McMahon is not an officer or Director of the Company. Mr. McMahon is a shareholder of MYHI stock.

Discontinued Operations

Discontinued Operations	12 Months Ended
	Mar. 31, 2016
Discontinued Operations and Disposal Groups [Abstract]
Discontinued Operations	Note 4 – Discontinued Operations The Company had no activity for discontinued operations year ended March 31, 2016. The Company had a loss from discontinued operations of $890,473 for the year ended March 31, 2015. The losses related to the discontinued Canna-Life operations that were sold in April 2015.

Equity

Equity	12 Months Ended
	Mar. 31, 2016
Equity [Abstract]
Equity	Note 5 – Equity Common Stock The Company has authorized 250,000,000 shares of common stock with a par value of $0.0001 per share and 250,000,000 shares of preferred stock with a par value of $0.0001 per share. On December 8, 2014, the Company issued 250,000 restricted shares of restricted common stock to Richard G. Stifel, the Company's CFO and a Director, for serving as a Director of the Company. The Company recorded an expense of $25,000 for the fair market value of these shares. During March 2015, the Company sold 420,000 restricted shares of common stock through a private placement at $0.15 per share. The Company received the $63,000 in FY 2015. The Company recorded the issuance of the stock in FY 2016, when the shares were actually delivered. During the year ended March 31, 2016 the Company issued 503,334 restricted shares through a private placement at $0.15 per share. On May 22, 2015, The Company issued 10,000,000 restricted shares to the shareholders of Greenlife Botanix pursuant to closing the Share Exchange Agreement dated February 8, 2015. The shares were valued at the fair market trading value, $0.23, on the closing date. The Company issued 353,600 restricted shares to a vendor in lieu of payment of $35,360 that was owed to the vendor at March 31, 2015. The shares were recorded at the fair market value of $0.25 per share or $88,400. The difference in value, $53,040, was written off as a loss on extinguishment of debt in the year ended March 31, 2016. Pursuant to agreements with potential investors; Alan Smith, CEO and a Director, retired 2,000,000 shares he received from the reverse merger referenced above. The share retirement was valued at par $0.0001 per share. Warrants On April 3, 2014, the Company’s entered into a consulting agreement with Dr. Bob Melamede. Pursuant to the consulting agreement, Dr. Melamede was to serve as a member of the Company’s newly formed Advisory Board and act as the Scientific Advisor of the Advisory Board for a term of 12 months. In exchange for Dr. Melamede’s services, he was to receive: (1) $10,000 per year, due and payable in advance; and (2) 300,000 common stock purchase warrants at an exercise price of $4.00 per share, that vested immediately. These warrants expired on April 3, 2016. The fair value of the 300,000 warrants was determined to be $1,257,000 in the fiscal year ended March 31, 2015, which was recorded as “Selling, general and administrative expenses” on the accompanying consolidated statement of operations. The fair value was determined using the Black-Scholes model with the following assumptions: · Dividend yield of 0% · Expected volatility of 215% · Risk-free interest rate of 0.24% · Expected life of 2.0 years The following ta ble summarizes the warrant activity: Weighted Weighted Average Average Remaining Aggregate Number of Exercise Contractual Intrinsic Warrants Price $ Life (in years) Value $ Outstanding, March 31, 2014 604,000 $ 4.75 Granted April 30, 2014 300,000 $ 4.00 Exercised — Forfeited/Canceled — Outstanding, March 31, 2016 904,000 $ 4.50 0.93 Exercisable, March 31, 2016 904,000 $ 4.50 0.93 $ — The number and weighted average exercise prices of all warrants outstanding as of March 31, 2016, are as follows: Warrants Outstanding and Exercisable Weighted Weighted Average Average Exercise Number Exercise Remaining Price $ of Warrants Price $ Life (Years) 4.00 300,000 4.00 0.01 4.75 604,000 4.75 0.93 904,000

Income Taxes

Income Taxes	12 Months Ended
	Mar. 31, 2016
Income Tax Disclosure [Abstract]
Income Taxes	Note 6 – Income Taxes The Company accounts for income taxes using the asset and liability approach in accounting for income taxes. Under this approach, deferred tax assets and liabilities are recognized based on anticipated future tax consequences, using currently enacted tax laws, attributable to temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts calculated for income tax purposes. The Company has federal net operating loss carryforwards of approximately $4,352,973 expiring in various years through 2036. The tax benefit of these net operating losses has been offset by a full allowance for realization. The use of the net operating loss carryfowards may be limited due to the change in control. Income tax expense (benefit) consists of the following for the year ended March 31, 2016: Current taxes $ — Deferred taxes 1,086,205 Less: valuation allowance (1,086,205 ) Net income tax provision $ — The Company’s effective tax rate differs from the high statutory rate for the period ended March 31, 2016, due to the following (expressed as a percentage of pre-tax income): Federal taxes at statutory rate $ 34.0 % State taxes, net of federal tax benefit 5.0 % Valuation allowance (39.0 )% Effective income tax rate $ 0.0 % As of March 31, 2016, the components of these temporary differences and the deferred tax asset were as follows: Deferred Tax assets: Net operating loss carryforward $ 2,150,457 Less: valuation allowance (2,150,457 ) Net deferred tax assets $ —

Notes Payable

Notes Payable	12 Months Ended
	Mar. 31, 2016
Debt Disclosure [Abstract]
Notes Payable	Note 7 - Notes Payable During the year ended March 31, 2016 the Company issued notes payable to private parties and converted some of its liabilities to the officers into notes payable. Each note had interest rates of 3%-5% and had a conversion provision allowing the holder to convert the note into shares of the Company

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Mar. 31, 2016
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 8 – Commitments and Contingencies None.

Subsequent Events

Subsequent Events	12 Months Ended
	Mar. 31, 2016
Subsequent Events [Abstract]
Subsequent Events	Note 9 – Subsequent Events During May 2016, the Company converted $102,097 of convertible notes payable into 4,333,333 shares of the Company's restricted stock and 2,473,131 shares of the Company's free trading stock. All shares were converted at $0.015 per share.

Summary of Significant Accoun17

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Mar. 31, 2016
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“US GAAP”). The accompanying consolidated financial statements have been presented in United States Dollars ($ or “USD”). The fiscal year end is March 31.
Principles of Consolidation	Principles of Consolidation The accounts of the Company and its wholly–owned subsidiary GreenLife Botanix are included in the accompanying consolidated financial statements. All intercompany balances and transactions were eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. It is possible that accounting estimates and assumptions may be material to the Company due to the levels of subjectivity and judgment involved.
Cash and Cash Equivalents	Cash and Cash Equivalents Cash and cash equivalents include cash on hand and cash in time deposits, certificates of deposit and all highly liquid debt instruments with original maturities of three months or less.
Revenue Recognition	Revenue Recognition In accordance with the Securities and Exchange Commission’s (“SEC”) Staff Accounting Bulletin No. 104, Revenue Recognition Persuasive evidence of an arrangement exists Delivery has occurred The sales price is fixed or determinable Collection is reasonably assured
Inventories	Inventories Inventories consisting of cosmetic products are stated at the lower of cost or market. Cost is determined using the first-in, first-out method and are adjusted to actual cost quarterly based on a physical count. Net realizable value is the estimated selling price in the ordinary course of business, less applicable variable selling expenses.
Intangible Assets	Intangible Assets The Company accounts for intangibles in accordance with ASC 350, Intangible-Goodwill and Other. The Company evaluates intangibles, at a minimum, on an annual basis and whenever events and changes in circumstances suggest that the carrying amount may not be recoverable. Impairment of intangibles is tested by comparing the carrying amount to the fair value. The fair values are estimated using undiscounted projected net cash flows. If the carrying amount exceeds its fair value, intangibles are considered impaired and a second step is performed to measure the amount of impairment loss, if any. The Company evaluates the impairment of intangibles as of the end of each fiscal year or whenever events or changes in circumstances indicate that an intangible asset’s carrying amount may not be recoverable. These circumstances include: · a significant decrease in the market value of an asset; · a significant adverse change in the extent or manner in which an asset is used; or · an accumulation of costs significantly in excess of the amount originally expected for the acquisition of an asset. The Company recognized an impairment expense related to intangible assets during the year ended March 31, 2016 of $2,300,000 and nil for the
Income Taxes	Income Taxes The Company accounts for income taxes in accordance with ASC Topic 740, Income Taxes Under ASC 740, a tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination. For tax positions not meeting the “more likely than not” test, no tax benefit is recorded. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above is reflected as a liability for unrecognized tax benefits in the balance sheets along with any associated interest and penalties that would be payable to the taxing authorities upon examination. Applicable interest and penalties associated with unrecognized tax benefits are classified as additional income taxes in the statements of operations. The open tax years are 2011, 2012, 2013, 2014, 2015 and 2016. The Company has no tax positions at March 31, 2016, or March 31, 2015, for which the ultimate deductibility is highly certain but for which there is uncertainty about the timing of such deductibility.
Basic and Diluted Loss Per Share	Basic and Diluted Loss Per Share Earnings per share is calculated in accordance with the ASC Topic 260, Earnings Per Share
Discontinued Operations	Discontinued Operations The Generally Accepted Accounting Principles framework requires special presentation treatment of discontinued operations. This requirement refers to the results of operations of a component of an entity that is either being held for sale or which has already been disposed of. The designated results of operations must be reported as a discontinued operation within the financial statements if both of the following conditions are present: · Resulting elimination . The disposal transaction will result in the operations and cash flows of the component being eliminated from company operations. · Continuing involvement . There will be no significant continuing involvement by the company in the operations of the component, once the disposal transaction has been completed. Continuing involvement implies the ability to influence the operating or financial policies of the disposed component. Due to the above requirements, the financial results relating to Canna-Life are classified as discontinued operations in the MYHI consolidated financial statements.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In April 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2014-08, Presentation of Financial Statements (Topic 205) and Property, Plant and Equipment (Topic 360) In September 2014, the FASB issued ASU No. 2014-10, Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation which removes the definition of a development stage entity from Topic 915, thereby removing the distinction between development stage entities and other reporting entities from U.S. GAAP. In addition, the amendments eliminate the requirements for development stage entities to (1) present inception-to-date information on the statements of operations, cash flows, and stockholders’ equity, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage. The amendment is effective for annual reporting periods beginning after December 15, 2014. Early application is permitted. The Company chose to adopt ASU No. 2014-10 in the period ended March 31, 2014. Other recent authoritative guidance issued by the FASB (including technical corrections to the FASB Accounting Standards Codification), the American Institute of Certified Public Accountants, and the SEC, did not, or are not expected to have a material effect on the Company’s consolidated financial statements.

Equity (Tables)

Equity (Tables)	12 Months Ended
	Mar. 31, 2016
Equity [Abstract]
Warrant activity	Weighted Weighted Average Average Remaining Aggregate Number of Exercise Contractual Intrinsic Warrants Price $ Life (in years) Value $ Outstanding, March 31, 2014 604,000 $ 4.75 Granted April 30, 2014 300,000 $ 4.00 Exercised — Forfeited/Canceled — Outstanding, March 31, 2016 904,000 $ 4.50 0.93 Exercisable, March 31, 2016 904,000 $ 4.50 0.93 $ —
Number and weighted average exercise price of all warrants outstanding	Warrants Outstanding and Exercisable Weighted Weighted Average Average Exercise Number Exercise Remaining Price $ of Warrants Price $ Life (Years) 4.00 300,000 4.00 0.01 4.75 604,000 4.75 0.93 904,000

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Mar. 31, 2016
Income Tax Disclosure [Abstract]
Income tax expense (benefit)	Current taxes $ — Deferred taxes 1,086,205 Less: valuation allowance (1,086,205 ) Net income tax provision $ —
Effective tax rate reconciliation	Federal taxes at statutory rate $ 34.0 % State taxes, net of federal tax benefit 5.0 % Valuation allowance (39.0 )% Effective income tax rate $ 0.0 %
Deferred tax assets	Deferred Tax assets: Net operating loss carryforward $ 2,150,457 Less: valuation allowance (2,150,457 ) Net deferred tax assets $ —

Organization and Basis of Pre20

Organization and Basis of Presentation (Details Narrative) - USD ($)	12 Months Ended
	Mar. 31, 2016	Mar. 31, 2015	May 22, 2015	May 19, 2015	Apr. 30, 2015	Mar. 06, 2014
Accounting Policies [Abstract]
Common stock acquired from Canna-Life						8,104,000
Common stock exchanged for Canna-Life stock						8,104,000
Common stock shares purchased from majority stockholder by Canna-Life CEO						120,000,000
Common stock returned to treasury by Canna-Life CEO for cancellation of shares						113,500,000
Aggregate shares of common stock issued and outstanding	33,418,934	24,142,000				23,892,000
Number of shares remaining owned by former stockholders of Canna-Life						14,604,000
Percentage of total common stock issued and outstanding owned by former stockholders of Canna-Life						61.00%
Net liabilities of legal acquirer, Mountain High Acquisitions Corp						$ 36,110
CL Agreement
Canna-Life shares sold, shares					8,104,000
Note payable to Evolution Equities as part of CL Agreement					$ 80,000
Debt extinguishment exchanged for CL Agreement	$ 490,416
Cash proceeds from CL Agreement	$ 1
FSF Agreement
Company shares issued to acquire controlling shares of Freedom Seed and Feed				31,429,000
Advances to FSF for operating expenses				$ 75,645
Greenlife Acquisition
Restricted shares issued to Greenlife shareholders	10,000,000
Interest in Greenlife acquired			100.00%
Market value of shares on date of issuance, per share			$ .23
Value of restricted shares issued	$ 2,300,000
Impairment of goodwill value expensed	$ 2,300,000

Going Concern (Details Narrativ

Going Concern (Details Narrative) - USD ($)	2 Months Ended	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2016	Mar. 31, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Net loss	$ (133,607)	$ (2,938,475)	$ (2,324,633)
Net cash used in operating activities		(355,839)	(107,545)
Accumulated deficit		(5,396,715)	$ (2,458,240)
Working capital deficit		$ (446,682)

Summary of Significant Accoun22

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	12 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Accounting Policies [Abstract]
Impairment expense related to intangible assets	$ 2,300,000
Antidilutive shares excluded from computation of loss per share, warrants outstanding	904,000

Advances from Stockholder (Deta

Advances from Stockholder (Details Narrative) - USD ($)	Mar. 31, 2016	Mar. 31, 2015
Debt Disclosure [Abstract]
Amount due to stockholder	$ 15,001	$ 441,895
Unsecured advance by GreenLife President	$ 16,100

Discontinued Operations (Detail

Discontinued Operations (Details Narrative) - USD ($)	12 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Discontinued Operations and Disposal Groups [Abstract]
Loss on discontinued operations		$ (890,473)

Equity - Warrant activity (Deta

Equity - Warrant activity (Details) - USD ($)	12 Months Ended
	Mar. 31, 2016	Mar. 31, 2015	Apr. 30, 2014	Mar. 31, 2014
Weighted average exercise price		$ 4
Outstanding
Number of warrants outstanding	904,000			604,000
Weighted average exercise price	$ 4.50			$ 4.75
Weighted average remaining contractual life	11 months 5 days
Granted
Number of warrants granted		300,000
Weighted average exercise price			$ 4
Exercised
Number of warrants exercised
Forteited/Canceled
Number of warrants forfeited/canceled
Exercisable
Number of warrants outstanding	904,000
Weighted average exercise price	$ 4.50
Weighted average remaining contractual life	11 months 5 days
Aggregate intrinsic value

Equity - Number and weighted av

Equity - Number and weighted average exercise price of all warrants outstanding (Details) - $ / shares	12 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Weighted average exercise price		$ 4
Warrants outstanding and exercisable (a)
Exercise price	$ 4
Number of warrants	300,000
Weighted average exercise price	$ 4
Weighted average remaining life	4 days
Warrants outstanding and exercisable (b)
Exercise price	$ 4.75
Number of warrants	604,000
Weighted average exercise price	$ 4.75
Weighted average remaining life	11 months 5 days
Warrants outstanding and exercisable (Total)
Number of warrants	904,000

Equity - Common Stock (Details

Equity - Common Stock (Details Narrative) - USD ($)	Dec. 08, 2014	Mar. 31, 2015	Mar. 31, 2016	Mar. 31, 2015	May 22, 2015
Equity [Abstract]
Common stock, authorized		250,000,000	250,000,000	250,000,000
Common stock, par value		$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, authorized		250,000,000	250,000,000	250,000,000
Preferred stock, par value		$ 0.0001	$ 0.0001	$ 0.0001
Shares of restricted common stock issued to CFO for serving as Director, shares	250,000
Shares of restricted common stock issued to CFO for serving as Director, recorded expense for fair market value	$ 25,000
Shares of common stock sold through private placement, shares		420,000
Shares of common stock sold through private placement, price per share		$ 0.15
Shares of common stock sold through private placement, proceeds received		$ 63,000
Restricted shares issued through private placement, shares			503,334
Restricted shares issued through private placement, per share			$ .15
Restricted shares issued to Greenlife shareholders			10,000,000
Market value of shares on date of issuance, per share					$ .23
Shares issued in lieu of payment owed to vendor, shares			353,600	250,000
Shares issued in lieu of payment owed to vendor, amount			$ 88,400	$ 25,000
Shares issued in lieu of payment owed to vendor, fair market value per share			$ .25
Difference in value written off as loss on extinguishment of debt			$ 53,040
Retire shares from reverse merger, shares			(2,000,000)

Equity - Warrants (Details Narr

Equity - Warrants (Details Narrative) - USD ($)	12 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Equity - Warrants Details Narrative
Consulting agreement annual payment		$ 10,000
Consulting agreement, common stock purchase warrants issued		300,000
Purchase warrants, exercise price		$ 4
Purchase warrants, expiration date		Apr. 3, 2016
Fair value of warrants issued for services		$ 1,257,000
Fair value assumptions, dividend yield		0.00%
Fair value assumptions, expected volatility		215.00%
Fair value assumptions, risk-free interest rate		0.24%
Fair value assumptions, expected life		2 years

Income Taxes - Income tax expen

Income Taxes - Income tax expense (benefit) (Details)	12 Months Ended
	Mar. 31, 2016USD ($)
Income Tax Disclosure [Abstract]
Current taxes
Deferred taxes	1,086,205
Less: valuation allowance	(1,086,205)
Net income tax provision

Income Taxes - Effective tax ra

Income Taxes - Effective tax rate reconciliation (Details)	12 Months Ended
	Mar. 31, 2016
Income Tax Disclosure [Abstract]
Federal taxes at statutory rate	34.00%
State taxes, net of federal tax benefit	5.00%
Valuation allowance	(39.00%)
Effective income tax rate	0.00%

Income Taxes - Deferred tax ass

Income Taxes - Deferred tax assets (Details)	Mar. 31, 2016USD ($)
Deferred Tax assets:
Net operating loss carryforward	$ 2,150,457
Less: valuation allowance	(2,150,457)
Net deferred tax assets

Income Taxes (Details Narrative

Income Taxes (Details Narrative)	Mar. 31, 2016USD ($)
Income Tax Disclosure [Abstract]
Operating loss carryforwards	$ 4,352,973

Notes Payable (Details Narrativ

Notes Payable (Details Narrative) - USD ($)	12 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Debt Disclosure [Abstract]
Interest Expense resulting from Beneficial Conversion Feature	$ (173,798)

Subsequent Events (Details Narr

Subsequent Events (Details Narrative)	1 Months Ended
	May 31, 2016USD ($)$ / sharesshares
Subsequent Events [Abstract]
Convertible notes payable, converted amount | $	$ 102,097
Convertible notes payable, converted restricted stock shares	4,333,333
Convertible notes payable, converted free trading stock shares	2,473,131
Convertible notes payable, conversion price | $ / shares	$ 0.015